Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Dal Bo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Tumori|August 31, 1991
Pattern and determinants of diagnostic interval in cancers of the prostate, bladder and kidneyR Talamini, S Franceschi, V Dal Bo, et al.
Progress in Clinical and Biological Research|January 1, 1988
Pre surgery chemotherapy in bladder cancerM Francini, A Veronesi, V Dal Bo, et al.
Tumori|June 30, 1987
Proliferative activity in human urologic malignancies: a preliminary studyS Veronese, R Volpe, V Dal Bo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Extrapulmonary small cell carcinoma: a single-institution experience and review of the literatureG Lo Re, V Canzonieri, A Veronesi, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tractA Veronesi, E Galligioni, G Lo Re, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Mitomycin C treatment of advanced, hormone-resistant prostatic carcinoma: a phase II studyA Veronesi, V Dal Bo, G Lo Re, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Multimodal treatment of locally advanced transitional cell bladder carcinoma in elderly patientsA Veronesi, G Lo Re, A Carbone, et al.
European Urology|January 1, 1992
Buserelin treatment of advanced prostatic carcinoma: prognostic factor analysisA Veronesi, G Lo Re, V Dal Bo, et al.
Chemotherapy Research and Practice|February 8, 2012
Developing central nervous system and vulnerability to platinum compoundsG Bernocchi, M G Bottone, V M Piccolini, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Buserelin treatment of advanced prostatic cancer: a phase II studyA Veronesi, G Lo Re, V Dal Bo, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Tumori|August 31, 1991
Pattern and determinants of diagnostic interval in cancers of the prostate, bladder and kidneyR Talamini, S Franceschi, V Dal Bo, et al.
Progress in Clinical and Biological Research|January 1, 1988
Pre surgery chemotherapy in bladder cancerM Francini, A Veronesi, V Dal Bo, et al.
Tumori|June 30, 1987
Proliferative activity in human urologic malignancies: a preliminary studyS Veronese, R Volpe, V Dal Bo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Extrapulmonary small cell carcinoma: a single-institution experience and review of the literatureG Lo Re, V Canzonieri, A Veronesi, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1986
Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tractA Veronesi, E Galligioni, G Lo Re, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Mitomycin C treatment of advanced, hormone-resistant prostatic carcinoma: a phase II studyA Veronesi, V Dal Bo, G Lo Re, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Multimodal treatment of locally advanced transitional cell bladder carcinoma in elderly patientsA Veronesi, G Lo Re, A Carbone, et al.
European Urology|January 1, 1992
Buserelin treatment of advanced prostatic carcinoma: prognostic factor analysisA Veronesi, G Lo Re, V Dal Bo, et al.
Chemotherapy Research and Practice|February 8, 2012
Developing central nervous system and vulnerability to platinum compoundsG Bernocchi, M G Bottone, V M Piccolini, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Buserelin treatment of advanced prostatic cancer: a phase II studyA Veronesi, G Lo Re, V Dal Bo, et al.
Pageof 2